Xelria Fe Kit
Product Images NDC 70700-308

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Xelria Fe (NDC 70700-308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Risk Of Breast Cancer With Combined Oral Contraceptive Use (Image 01)

A horizontal forest plot chart comparing effect estimates (Odds Ratio/Relative Risk) from various women's health studies, including NICHD, French E3N, Shanghai, Nurses' Health Study, Oxford Family Planning, and Danish Sex Hormone Register. Each study is represented with effect estimate points and confidence intervals along the x-axis labeled 'Effect Estimate (OR/RR)' ranging approximately from -1.5 to 2.*

FDA Label Image

Norethindrone And Ethinyl Estradiol Structural Formulas (Image 02)

Chemical structure diagram showing the molecular formulas of norethindrone and ethinyl estradiol, the active ingredients in Xelria Fe. The structures depict the steroidal frameworks with specific functional groups indicated.*

FDA Label Image

Patient Information Figure 1 (Image 03)

A diagram illustrating the effectiveness of various birth control methods in reducing pregnancy rates per 100 women in one year. It categorizes methods from fewer than 1 pregnancy to 85 or more pregnancies, listing implants, injections, intrauterine devices, and sterilization as most effective; birth control pills, skin patch, and vaginal ring as moderately effective; condoms and diaphragm as less effective; no sex during fertile days, spermicide, and withdrawal as even less effective; and no birth control with the highest pregnancy rate.*

FDA Label Image

Figure A (Image 04)

Diagram of a 28-tablet dose pack for Xelria Fe containing chewable norethindrone, ethinyl estradiol, and ferrous fumarate tablets. It shows a weekly schedule with active tablets for weeks 1 to 3 and inactive tablets in week 4. Each tablet is arranged in circles labeled by day of the week from Sunday to Saturday with arrows indicating the dosing order.*

FDA Label Image

Norethindrone And Ethinyl Estradiol Chewable Tablets And Ferrous Fumarate Chewable Tablets 0.4 mg/0.035 mg Carton Label (Image 05)

Packaging label for Xelria Fe 0.4 mg/0.035 mg kit by Xiromed LLC. The label identifies the product as containing chewable norethindrone and ethinyl estradiol tablets along with ferrous fumarate tablets. The kit includes three pouches, each containing a blister pack of 28 tablets. The label features orange accents and the Xiromed logo.*

FDA Label Image

Figure B (Image 06)

Illustration showing hands holding a blister pack of tablets with arrows indicating pressing or pushing actions on the tablets, likely demonstrating how to remove tablets from the packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.